Business Context and Reporting Period
Company: Achieve Life Sciences, Inc. (ACHV)
Filing Type: Form 8-K (Current Report)
Report Date: August 11, 2026
Reporting Period: Second Quarter ended June 30, 2026
Context: The filing announces the issuance of a press release detailing financial results for the second quarter of 2026.
Key Financial Metrics
The provided Form 8-K text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not provide clear values for the following metrics:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
The Form 8-K text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These disclosures are contained within the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 11, 2026) for actual Q2 2026 financial figures.
- Verify the company's cash runway and burn rate given the lack of explicit liquidity data in this summary document.
- Check for any updates on clinical trial progress or regulatory milestones typically included in the full press release.
- Confirm if the "furnished" status of the financial data affects its legal standing for incorporation by reference in other filings.